These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
3. [Genetic screening for familial hypercholesterolemia in 1992-1997: primarily younger patients in the care of family physicians]. ten Asbroek AH; van Lunsen S; Marang-van de Mheen PJ; Gunning-Schepers LJ Ned Tijdschr Geneeskd; 2000 Jan; 144(3):125-9. PubMed ID: 10674119 [TBL] [Abstract][Full Text] [Related]
4. Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC). Futema M; Cooper JA; Charakida M; Boustred C; Sattar N; Deanfield J; Lawlor DA; Timpson NJ; ; Humphries SE; Hingorani AD Atherosclerosis; 2017 May; 260():47-55. PubMed ID: 28349888 [TBL] [Abstract][Full Text] [Related]
5. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing. Humphries SE; Cranston T; Allen M; Middleton-Price H; Fernandez MC; Senior V; Hawe E; Iversen A; Wray R; Crook MA; Wierzbicki AS J Mol Med (Berl); 2006 Mar; 84(3):203-14. PubMed ID: 16389549 [TBL] [Abstract][Full Text] [Related]
6. Familial hypercholesterolaemia in a Belgian community. Descamps OS Acta Cardiol; 2000 Dec; 55(6):327-33. PubMed ID: 11227832 [TBL] [Abstract][Full Text] [Related]
7. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia. Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182 [TBL] [Abstract][Full Text] [Related]
8. Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal. Huijgen R; Kindt I; Verhoeven SB; Sijbrands EJ; Vissers MN; Kastelein JJ; Hutten BA PLoS One; 2010 Feb; 5(2):e9220. PubMed ID: 20169164 [TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Umans-Eckenhausen MA; Sijbrands EJ; Kastelein JJ; Defesche JC Circulation; 2002 Dec; 106(24):3031-6. PubMed ID: 12473547 [TBL] [Abstract][Full Text] [Related]
11. Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project. Hadfield SG; Horara S; Starr BJ; Yazdgerdi S; Bhatnagar D; Cramb R; Egan S; Everdell R; Ferns G; Jones A; Marenah CB; Marples J; Prinsloo P; Sneyd A; Stewart MF; Sandle L; Wang T; Watson MS; Humphries SE Ann Clin Biochem; 2008 Mar; 45(Pt 2):199-205. PubMed ID: 18325186 [TBL] [Abstract][Full Text] [Related]
12. Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing. Starr B; Hadfield SG; Hutten BA; Lansberg PJ; Leren TP; Damgaard D; Neil HA; Humphries SE Clin Chem Lab Med; 2008; 46(6):791-803. PubMed ID: 18601600 [TBL] [Abstract][Full Text] [Related]
13. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers. Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147 [TBL] [Abstract][Full Text] [Related]
15. Molecular genetics of familial hypercholesterolaemia in Norway. Leren TP; Tonstad S; Gundersen KE; Bakken KS; Rødningen OK; Sundvold H; Ose L; Berg K J Intern Med; 1997 Mar; 241(3):185-94. PubMed ID: 9104431 [TBL] [Abstract][Full Text] [Related]
16. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience. Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028 [TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of familial hypercholesterolaemia in Western Australia. Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975 [TBL] [Abstract][Full Text] [Related]
19. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population. Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677 [TBL] [Abstract][Full Text] [Related]
20. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk. Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]